Centennial Bank’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$181K Hold
800
– – 0.05% 155
2026
Q2
$173K Hold
800
– – 0.06% 159
2026
Q1
$147K Hold
800
– – 0.05% 157
2025
Q4
$141K Hold
800
– – 0.06% 158
2025
Q3
$112K Hold
800
– – 0.04% 169
2025
Q2
$100K Hold
800
– – 0.04% 175
2025
Q1
$109K Hold
800
– – 0.05% 164
2024
Q4
$122K Hold
800
– – 0.06% 151
2024
Q3
$155K Hold
800
– – 0.07% 141
2024
Q2
$185K Hold
800
– – 0.09% 128
2024
Q1
$173K Hold
800
– – 0.09% 129
2023
Q4
$207K Hold
800
– – 0.12% 122
2023
Q3
$206K Sell
800
-350
-30% -$93.6K 0.14% 119
2023
Q2
$328K Hold
1,150
– – 0.22% 92
2023
Q1
$320K Hold
1,150
– – 0.21% 104
2022
Q4
$318K Buy
+1,150
New +$325K 0.18% 112

Other funds holding BIIB

Centennial Bank's BIIB Position: Q3 2026 in Review

Centennial Bank held its Biogen (BIIB) position steady in Q3 2026 at 800 shares worth $181K. The position accounts for 0.05% of the portfolio, ranked #155.

Centennial Bank first reported a position in BIIB in Q4 2022 and has held it in 16 quarters since. The position peaked at $328K in Q2 2023. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Centennial Bank held 800 shares of Biogen worth $181K as of Q3 2026.
  • Centennial Bank left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.05% of Centennial Bank's portfolio in Q3 2026, its #155 holding.
  • Centennial Bank first reported a position in Biogen in Q4 2022 and has held it in 16 quarters since.
  • Centennial Bank's Biogen position peaked at $328K in Q2 2023.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Centennial Bank's 13F filing for Q3 2026, filed 9 Nov 2026.